Trials / Recruiting
RecruitingNCT06278987
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PENG block and cryoablation | will receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves. |
| DRUG | fascia iliaca compartment block | will receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-10-01
- Completion
- 2027-10-01
- First posted
- 2024-02-26
- Last updated
- 2025-11-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06278987. Inclusion in this directory is not an endorsement.